المؤلفون: Annunziata Gloghini, Maurizio Colecchia, Patrizia Giannatempo, Chiara C. Volpi, Daniele Raggi, Andrea Necchi

المساهمون: Necchi, A, Raggi, D, Volpi, Cc, Giannatempo, P, Colecchia, M, Gloghini, A

المصدر: European Urology Focus. 5:689-692

مصطلحات موضوعية: Male, 0301 basic medicine, Urologic Neoplasms, Pathology, medicine.medical_specialty, Urology, medicine.disease_cause, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, medicine, Humans, RNA, Messenger, Receptor, Fibroblast, Gene, Aged, Neoplasm Staging, Retrospective Studies, Carcinoma, Transitional Cell, Messenger RNA, Mutation, business.industry, RNA, DNA, Neoplasm, Middle Aged, Receptors, Fibroblast Growth Factor, 030104 developmental biology, medicine.anatomical_structure, chemistry, Fibroblast growth factor receptor, 030220 oncology & carcinogenesis, Cancer research, Female, business, DNA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::095598a44bae74d1b285a33f6c2c0898
https://doi.org/10.1016/j.euf.2017.08.002

المؤلفون: Sala L; Department of Plastic Reconstructive Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Ciniselli CM; Unit of Bioinformatics and Biostatistics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Bozzi F; Department of Diagnostics Innovation, Pathology Unit 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Summo V; Department of Plastic Reconstructive Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Bonini C; Unit of laboratory Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Lombardia, Italy., Brich S; Department of Diagnostics Innovation, Pathology Unit 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Bertolotti A; Department of Diagnostics Innovation, Pathology Unit 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Trupia DV; Department of Diagnostics Innovation, Pathology Unit 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Volpi CC; Department of Diagnostics Innovation, Pathology Unit 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Pizzamiglio S; Unit of Bioinformatics and Biostatistics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Paolini B; Department of Diagnostics Innovation, Pathology Unit 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Aiello A; Department of Diagnostics Innovation, Pathology Unit 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Apolone G; Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Verderio P; Unit of Bioinformatics and Biostatistics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy., Cortinovis U; Department of Plastic Reconstructive Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy.

المصدر: Tumori [Tumori] 2024 Feb; Vol. 110 (1), pp. 49-59. Date of Electronic Publication: 2023 Aug 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 0111356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2038-2529 (Electronic) Linking ISSN: 03008916 NLM ISO Abbreviation: Tumori Subsets: MEDLINE

مواضيع طبية MeSH: Breast Implants* , Mammaplasty*/methods , Breast Neoplasms*, Female ; Humans ; Inflammation

المؤلفون: Kusamura S; Peritoneal Surface Malignancy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Busico A; Laboratory of Diagnostic and Molecular Research, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Conca E; Laboratory of Diagnostic and Molecular Research, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Capone I; Laboratory of Diagnostic and Molecular Research, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Agnelli L; Laboratory of Diagnostic and Molecular Research, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.; Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Lorenzini D; Laboratory of Diagnostic and Molecular Research, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Brich S; Laboratory of Diagnostic and Molecular Research, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Angelini M; Laboratory of Diagnostic and Molecular Research, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Volpi CC; Laboratory of Diagnostic and Molecular Research, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Trupia DV; Laboratory of Diagnostic and Molecular Research, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Lagano V; 1st Pathology Division, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Torelli T; Laboratory of Diagnostic and Molecular Research, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Gloghini A; Laboratory of Diagnostic and Molecular Research, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Baratti D; Peritoneal Surface Malignancy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Guaglio M; Peritoneal Surface Malignancy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Milione M; 1st Pathology Division, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Deraco M; Peritoneal Surface Malignancy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy., Perrone F; Laboratory of Diagnostic and Molecular Research, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.

المصدر: Biomedicines [Biomedicines] 2023 Jul 20; Vol. 11 (7). Date of Electronic Publication: 2023 Jul 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE

المؤلفون: D'Agostino M; Experimental Immunology Laboratory, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy., Di Cecco M; Experimental Immunology Laboratory, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy., Marani C; Division of Histopathology, Ospedale San Carlo di Nancy, 00165 Rome, Italy., Vigili MG; Head and Neck Surgery Departments, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy., Sileno S; Institute of Translational Pharmacology IFT, National Research Council of Italy (CNR), 00133 Rome, Italy., Volpi CC; Diagnostic Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy., Gloghini A; Diagnostic Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy., Avitabile D; Idi Farmaceutici S.R.L., Pomezia, 00071 Rome, Italy., Magenta A; Institute of Translational Pharmacology IFT, National Research Council of Italy (CNR), 00133 Rome, Italy., Rahimi S; Anatomic Pathology Department, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 09; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Squamous Cell*/pathology , Head and Neck Neoplasms* , Oncogene Proteins, Viral*/genetics , Oropharyngeal Neoplasms*/pathology , Papillomavirus Infections*, Humans ; Cyclin-Dependent Kinase Inhibitor p16 ; DNA, Viral/genetics ; Human Papillomavirus Viruses ; Nucleophosmin ; Papillomaviridae/genetics ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck ; Viral Load

المؤلفون: Pruneri G; Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy. giancarlo.pruneri@istitutotumori.mi.it.; University of Milan, School of Medicine, Milan, Italy. giancarlo.pruneri@istitutotumori.mi.it., Lorenzini D; Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy., Mastropasqua MG; Department of Emergency and Organs Transplantation, Section of Anatomic Pathology, School of Medicine, University of Bari 'Aldo Moro', Bari, Italy., Perrone G; Research Unit of Pathology, Campus Bio-Medico University, Rome, Italy., Rizzo A; U.O. Anatomia Patologica, Humanitas Istituto Clinico Catanese, Catania, Italy., Santini D; Pathology Unit, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Volpi CC; Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy., Cinieri S; Medical Oncology Division and Breast Unit, Senatore Antonio Perrino Hospital, ASL Brindisi, Brindisi, Italy., Zambelli A; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy., Sapino A; Candiolo Cancer Institute, FPO-IRCCS Candiolo, Candiolo, Italy.; Department of Medical Science, University of Turin, Turin, Italy., Castellano I; Department of Medical Science, University of Turin, Turin, Italy.

المصدر: NPJ breast cancer [NPJ Breast Cancer] 2023 Jan 25; Vol. 9 (1), pp. 3. Date of Electronic Publication: 2023 Jan 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

المؤلفون: Vingiani A; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy.; Department of Oncology and Hematoncology, University of Milan, Milan, Italy.; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy., Lorenzini D; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy.; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy., Conca E; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy.; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy., Volpi CC; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy., Trupia DV; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy., Gloghini A; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy., Perrone F; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy., Tamborini E; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy., Dagrada GP; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy., Agnelli L; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy., Capone I; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy., Busico A; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy.; Department of Oncology and Hematoncology, University of Milan, Milan, Italy., Pruneri G; Department of Diagnostic Innovation, Foundation IRCCS National Cancer Institute, Milan, Italy.; Department of Oncology and Hematoncology, University of Milan, Milan, Italy.; Department of Oncology and Hematoncology, University of Milan, Milan, Italy.

المصدر: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2023; Vol. 38 (3), pp. 301-309.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101256509 Publication Model: Print Cited Medium: Internet ISSN: 1875-8592 (Electronic) Linking ISSN: 15740153 NLM ISO Abbreviation: Cancer Biomark Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/diagnosis , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Humans ; Immunohistochemistry ; Prospective Studies ; Retrospective Studies ; Workflow

المؤلفون: Corallo S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fucà G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Morano F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Salati M; Oncology and Hematology Department, Division of Oncology, University of Modena and Reggio Emilia, Modena, Italy., Spallanzani A; Oncology and Hematology Department, Division of Oncology, University of Modena and Reggio Emilia, Modena, Italy., Gloghini A; Diagnostic Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Volpi CC; Diagnostic Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Trupia DV; Diagnostic Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lobefaro R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Guarini V; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Milione M; Diagnostic Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cattaneo L; Diagnostic Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Antista M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Prisciandaro M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Raimondi A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sposito C; Hepato-Pancreatic-Biliary Surgery and Liver Transplantation Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mazzaferro V; Hepato-Pancreatic-Biliary Surgery and Liver Transplantation Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy., de Braud F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy., Di Bartolomeo M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

المصدر: The oncologist [Oncologist] 2020 Sep; Vol. 25 (9), pp. 780-786. Date of Electronic Publication: 2020 Apr 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Epstein-Barr Virus Infections*/complications , Stomach Neoplasms*/drug therapy, Cohort Studies ; Herpesvirus 4, Human ; Humans ; Prognosis

المؤلفون: Volpi CC; Department of the Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pietrantonio F; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Faculty of Medicine, Oncology and Hemato-Oncology Department, Università degli Studi di Milano, Milan, Italy., Gloghini A; Department of the Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fucà G; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Giordano S; Department of Oncology, University of Turin, Turin, Italy.; Candiolo Cancer Institute, FPO - IRCCS - Candiolo (TO), Turin, Italy., Corso S; Department of Oncology, University of Turin, Turin, Italy.; Candiolo Cancer Institute, FPO - IRCCS - Candiolo (TO), Turin, Italy., Pruneri G; Department of the Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Antista M; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cremolini C; Unit of Medical Oncology, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy., Fasano E; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Saggio S; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Faraci S; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Bartolomeo M; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., de Braud F; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Faculty of Medicine, Oncology and Hemato-Oncology Department, Università degli Studi di Milano, Milan, Italy., Di Nicola M; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tagliabue E; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pupa SM; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. serenella.pupa@istitutotumori.mi.it., Castagnoli L; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

المصدر: Scientific reports [Sci Rep] 2020 Apr 24; Vol. 10 (1), pp. 7210. Date of Electronic Publication: 2020 Apr 24.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Belfiore A; Laboratory of Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Busico A; Laboratory of Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Bozzi F; Laboratory of Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Brich S; Laboratory of Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Dallera E; Laboratory of Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Conca E; Laboratory of Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Capone I; Laboratory of Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Gloghini A; Laboratory of Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Volpi CC; Laboratory of Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Cabras AD; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Pilotti S; Laboratory of Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Baratti D; Peritoneal Surface Malignancy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Guaglio M; Peritoneal Surface Malignancy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Deraco M; Peritoneal Surface Malignancy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Kusamura S; Peritoneal Surface Malignancy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy., Perrone F; Laboratory of Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milan, Italy.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2019 Nov 19; Vol. 20 (22). Date of Electronic Publication: 2019 Nov 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms/*genetics , Mesothelioma/*genetics , Peritoneal Neoplasms/*genetics, Adult ; Aged ; Cell Line, Tumor ; Combined Modality Therapy/methods ; Down-Regulation/drug effects ; Down-Regulation/genetics ; Female ; Humans ; Lung Neoplasms/drug therapy ; Male ; Mesothelioma/drug therapy ; Mesothelioma, Malignant ; MicroRNAs/genetics ; Middle Aged ; Neoplasm Recurrence, Local/genetics ; Peritoneal Neoplasms/drug therapy ; Peritoneum/drug effects ; Protein Kinase Inhibitors/therapeutic use ; RNA, Messenger/genetics

المؤلفون: Imbimbo M; Head and Neck Cancer Medical Oncology 3 Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Alfieri S; Head and Neck Cancer Medical Oncology 3 Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Botta L; Evaluative Epidemiology, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bergamini C; Head and Neck Cancer Medical Oncology 3 Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gloghini A; Diagnostic Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Calareso G; Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Orlandi E; Radiotherapy Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Iacovelli NA; Radiotherapy Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Guzzo M; Head and Neck Surgery Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Granata R; Head and Neck Cancer Medical Oncology 3 Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Resteghini C; Head and Neck Cancer Medical Oncology 3 Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Locati L; Head and Neck Cancer Medical Oncology 3 Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Volpi CC; Diagnostic Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Licitra L; Head and Neck Cancer Medical Oncology 3 Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; University of Milan, Milan, Italy., Bossi P; Head and Neck Cancer Medical Oncology 3 Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

المصدر: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery [Otolaryngol Head Neck Surg] 2019 Oct; Vol. 161 (4), pp. 635-642. Date of Electronic Publication: 2019 Jul 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 8508176 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6817 (Electronic) Linking ISSN: 01945998 NLM ISO Abbreviation: Otolaryngol Head Neck Surg Subsets: MEDLINE

مواضيع طبية MeSH: Aftercare*, Head and Neck Neoplasms/*therapy , Neoplasm Recurrence, Local/*diagnostic imaging, Academic Medical Centers ; Adult ; Aged ; Aged, 80 and over ; Combined Modality Therapy ; Female ; Head and Neck Neoplasms/diagnostic imaging ; Head and Neck Neoplasms/mortality ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Recurrence, Local/therapy ; Neoplasms, Second Primary/therapy ; Population Surveillance ; Positron-Emission Tomography ; Retrospective Studies ; Salvage Therapy ; Survival Analysis ; Tomography, X-Ray Computed ; Young Adult